AAAAAA

   
Results: 1-25 | 26-32
Results: 1-25/32
RESULTS OF PHASE-III EXCIMER-LASER PHOTOREFRACTIVE KERATECTOMY FOR MYOPIA
Authors: HERSH PS STULTING RD STEINERT RF WARING GO THOMPSON KP OCONNELL M DONEY K SCHEIN OD MICHELSON M OWEN J GORDON M WRIGHT JR BRINT S STEINERT R MEAD M RAIZMAN M WU H DURRIE D CAVANAUGH T HUNKELER J PEPOSE J GALUSHA JH GOLD DH MILSTEIN BA
Citation: Ps. Hersh et al., RESULTS OF PHASE-III EXCIMER-LASER PHOTOREFRACTIVE KERATECTOMY FOR MYOPIA, Ophthalmology, 104(10), 1997, pp. 1535-1553
CONVERSION TO FK506 FOR CYCLOSPORINE (CSP)-RESISTANT ACUTE GVHD OR CSP-ASSOCIATED TOXICITY
Authors: FURLONG T STORB R ANASETTI C APPELBAUM F DEEG HJ DONEY K MARTIN P SULLIVAN KM WITHERSPOON R NASH RA
Citation: T. Furlong et al., CONVERSION TO FK506 FOR CYCLOSPORINE (CSP)-RESISTANT ACUTE GVHD OR CSP-ASSOCIATED TOXICITY, Blood, 90(10), 1997, pp. 458-458
MYCOPHENOLATE MOFETIL (MMF) AS SALVAGE TREATMENT FOR GRAFT-VERSUS-HOST DISEASE (GVHD) AFTER ALLOGENEIC HEMATOPOIETIC STEM-CELL TRANSPLANTATION (HSCT) - SAFETY ANALYSIS
Authors: NASH RA FURLONG T STORB R ANASETTI C APPELBAUM FR DEEG HJ DONEY K MARTIN P WITHERSPOON R SULLIVAN KM
Citation: Ra. Nash et al., MYCOPHENOLATE MOFETIL (MMF) AS SALVAGE TREATMENT FOR GRAFT-VERSUS-HOST DISEASE (GVHD) AFTER ALLOGENEIC HEMATOPOIETIC STEM-CELL TRANSPLANTATION (HSCT) - SAFETY ANALYSIS, Blood, 90(10), 1997, pp. 459-459
USE OF STEM-CELL FACTOR (STEGMEN(R), SCF) AND FILGRASTIM (G-CSF) IN APLASTIC-ANEMIA (AA) PATIENTS (PTS) WHO HAVE FAILED ATG ALG THERAPY/
Authors: KURZROCK R PAQUETTE R GRATWOHL A DONEY K GABRILOVE J PATTERSON M RIVERA C WYRES M DAVIS MW YOUNG N
Citation: R. Kurzrock et al., USE OF STEM-CELL FACTOR (STEGMEN(R), SCF) AND FILGRASTIM (G-CSF) IN APLASTIC-ANEMIA (AA) PATIENTS (PTS) WHO HAVE FAILED ATG ALG THERAPY/, Blood, 90(10), 1997, pp. 762-762
CYCLOSPORINE OR CYCLOSPORINE PLUS METHYLPREDNISOLONE FOR PROPHYLAXIS OF GRAFT-VERSUS-HOST DISEASE - A PROSPECTIVE, RANDOMIZED TRIAL
Authors: DEEG HJ LIN DY LEISENRING W BOECKH M ANASETTI C APPELBAUM FR CHAUNCEY TR DONEY K FLOWERS M MARTIN P NASH R SCHOCH G SULLIVAN KM WITHERSPOON RP STORB R
Citation: Hj. Deeg et al., CYCLOSPORINE OR CYCLOSPORINE PLUS METHYLPREDNISOLONE FOR PROPHYLAXIS OF GRAFT-VERSUS-HOST DISEASE - A PROSPECTIVE, RANDOMIZED TRIAL, Blood, 89(10), 1997, pp. 3880-3887
PRIMARY-TREATMENT OF ACQUIRED APLASTIC-ANEMIA - OUTCOMES WITH BONE-MARROW TRANSPLANTATION AND IMMUNOSUPPRESSIVE THERAPY
Authors: DONEY K LEISENRING W STORB R APPELBAUM FR
Citation: K. Doney et al., PRIMARY-TREATMENT OF ACQUIRED APLASTIC-ANEMIA - OUTCOMES WITH BONE-MARROW TRANSPLANTATION AND IMMUNOSUPPRESSIVE THERAPY, Annals of internal medicine, 126(2), 1997, pp. 107
ALLOGENEIC MARROW TRANSPLANTATION FOR MYELODYSPLASTIC SYNDROME WITH ADVANCED DISEASE MORPHOLOGY - A PHASE-II STUDY OF BUSULFAN, CYCLOPHOSPHAMIDE, AND TOTAL-BODY IRRADIATION AND ANALYSIS OF PROGNOSTIC FACTORS
Authors: ANDERSON JE APPELBAUM FR SCHOCH G GOOLEY T ANASETTI C BENSINGER WI BRYANT E BUCKNER CD CHAUNCEY T CLIFT RA DEEG HJ DONEY K FLOWERS M HANSEN JA MARTIN PJ MATTHEWS DC NASH RA SANDERS JE SHULMAN H SULLIVAN KM WITHERSPOON RP STORB R
Citation: Je. Anderson et al., ALLOGENEIC MARROW TRANSPLANTATION FOR MYELODYSPLASTIC SYNDROME WITH ADVANCED DISEASE MORPHOLOGY - A PHASE-II STUDY OF BUSULFAN, CYCLOPHOSPHAMIDE, AND TOTAL-BODY IRRADIATION AND ANALYSIS OF PROGNOSTIC FACTORS, Journal of clinical oncology, 14(1), 1996, pp. 220-226
RECOMBINANT INTERLEUKIN-1 FOLLOWED BY IMMUNOSUPPRESSIVE THERAPY FOR APLASTIC-ANEMIA
Authors: DONEY K STORB R LILLEBY K APPELBAUM FR
Citation: K. Doney et al., RECOMBINANT INTERLEUKIN-1 FOLLOWED BY IMMUNOSUPPRESSIVE THERAPY FOR APLASTIC-ANEMIA, American journal of hematology, 52(1), 1996, pp. 61-62
BONE-MARROW TRANSPLANTATION FOR SEVERE APLASTIC-ANEMIA FROM GENOTYPICALLY HLA-NONIDENTICAL RELATIVES - AN UPDATE OF THE SEATTLE EXPERIENCE
Authors: WAGNER JL DEEG HJ SEIDEL K ANASETTI C DONEY K SANDERS J SULLIVAN KM STORB R
Citation: Jl. Wagner et al., BONE-MARROW TRANSPLANTATION FOR SEVERE APLASTIC-ANEMIA FROM GENOTYPICALLY HLA-NONIDENTICAL RELATIVES - AN UPDATE OF THE SEATTLE EXPERIENCE, Transplantation, 61(1), 1996, pp. 54-61
MARROW TRANSPLANTATION FOR FANCONI-ANEMIA - CONDITIONING WITH REDUCEDDOSES OF CYCLOPHOSPHAMIDE WITHOUT RADIATION
Authors: FLOWERS MED ZANIS J PASQUINI R DEEG HJ RIBEIRO R LONGTON G MEDEIROS CR DONEY K SANDERS J BRYANT E HANSEN J SULLIVAN KM APPELBAUM F THOMAS ED STORB R
Citation: Med. Flowers et al., MARROW TRANSPLANTATION FOR FANCONI-ANEMIA - CONDITIONING WITH REDUCEDDOSES OF CYCLOPHOSPHAMIDE WITHOUT RADIATION, British Journal of Haematology, 92(3), 1996, pp. 699-706
PREGNANCIES FOLLOWING HIGH-DOSE CYCLOPHOSPHAMIDE WITH OR WITHOUT HIGH-DOSE BUSULFAN OR TOTAL-BODY IRRADIATION AND BONE-MARROW TRANSPLANTATION
Authors: SANDERS JE HAWLEY J LEVY W GOOLEY T BUCKNER CD DEEG HJ DONEY K STORB R SULLIVAN K WITHERSPOON R APPELBAUM FR
Citation: Je. Sanders et al., PREGNANCIES FOLLOWING HIGH-DOSE CYCLOPHOSPHAMIDE WITH OR WITHOUT HIGH-DOSE BUSULFAN OR TOTAL-BODY IRRADIATION AND BONE-MARROW TRANSPLANTATION, Blood, 87(7), 1996, pp. 3045-3052
ALLOGENEIC MARROW TRANSPLANTATION FOR REFRACTORY-ANEMIA - A COMPARISON OF 2 PREPARATIVE REGIMENS AND ANALYSIS OF PROGNOSTIC FACTORS
Authors: ANDERSON JE APPELBAUM FR SCHOCH G GOOLEY T ANASETTI C BENSINGER WI BRYANT E BUCKNER CD CHAUNCEY TR CLIFT RA DONEY K FLOWERS M HANSEN JA MARTIN PJ MATTHEWS DC SANDERS JE SHULMAN H SULLIVAN KM WITHERSPOON RP STORB R
Citation: Je. Anderson et al., ALLOGENEIC MARROW TRANSPLANTATION FOR REFRACTORY-ANEMIA - A COMPARISON OF 2 PREPARATIVE REGIMENS AND ANALYSIS OF PROGNOSTIC FACTORS, Blood, 87(1), 1996, pp. 51-58
HIGH-DOSE CYCLOPHOSPHAMIDE, CARMUSTINE, AND ETOPOSIDE FOLLOWED BY ALLOGENEIC BONE-MARROW TRANSPLANTATION IN PATIENTS WITH LYMPHOID MALIGNANCIES WHO HAD RECEIVED PRIOR DOSE-LIMITING RADIATION-THERAPY
Authors: DEMIRER T WEAVER CH BUCKNER CD PETERSEN FB BENSINGER WI SANDERS J CLIFT RA LILLEBY K ANASETTI C MARTIN P STORB R CHAUNCEY T DONEY K SULLIVAN K APPELBAUM FR
Citation: T. Demirer et al., HIGH-DOSE CYCLOPHOSPHAMIDE, CARMUSTINE, AND ETOPOSIDE FOLLOWED BY ALLOGENEIC BONE-MARROW TRANSPLANTATION IN PATIENTS WITH LYMPHOID MALIGNANCIES WHO HAD RECEIVED PRIOR DOSE-LIMITING RADIATION-THERAPY, Journal of clinical oncology, 13(3), 1995, pp. 596-602
ALLOGENEIC MARROW TRANSPLANTATION FOLLOWING CYCLOPHOSPHAMIDE AND ESCALATING DOSES OF HYPERFRACTIONATED TOTAL-BODY IRRADIATION IN PATIENTS WITH ADVANCED LYMPHOID MALIGNANCIES - A PHASE I II TRIAL/
Authors: DEMIRER T PETERSEN FB APPELBAUM FR BARNETT TA SANDERS J DEEG HJ STORB R DONEY K BENSINGER WI SHANNONDORCY K BUCKNER CD
Citation: T. Demirer et al., ALLOGENEIC MARROW TRANSPLANTATION FOLLOWING CYCLOPHOSPHAMIDE AND ESCALATING DOSES OF HYPERFRACTIONATED TOTAL-BODY IRRADIATION IN PATIENTS WITH ADVANCED LYMPHOID MALIGNANCIES - A PHASE I II TRIAL/, International journal of radiation oncology, biology, physics, 32(4), 1995, pp. 1103-1109
MARROW HARVESTING FROM DONORS GREATER-THAN-OR-EQUAL-TO-65 YEARS OF AGE
Authors: DONEY K BUCKNER CD STORB R
Citation: K. Doney et al., MARROW HARVESTING FROM DONORS GREATER-THAN-OR-EQUAL-TO-65 YEARS OF AGE, Experimental hematology, 23(8), 1995, pp. 861-861
TACROLIMUS (FK506) ALONE OR IN COMBINATION WITH METHOTREXATE OR METHYLPREDNISOLONE FOR THE PREVENTION OF ACUTE GRAFT-VERSUS-HOST DISEASE AFTER MARROW TRANSPLANTATION FROM HLA-MATCHED SIBLINGS - A SINGLE-CENTERSTUDY
Authors: NASH RA ETZIONI R STORB R FURLONG T GOOLEY T ANASETTI C APPELBAUM FR DONEY K MARTIN P SLATTERY J SULLIVAN K VANDERJAGT R WITHERSPOON R JUSKO WJ ZAGER RA DEEG HJ
Citation: Ra. Nash et al., TACROLIMUS (FK506) ALONE OR IN COMBINATION WITH METHOTREXATE OR METHYLPREDNISOLONE FOR THE PREVENTION OF ACUTE GRAFT-VERSUS-HOST DISEASE AFTER MARROW TRANSPLANTATION FROM HLA-MATCHED SIBLINGS - A SINGLE-CENTERSTUDY, Blood, 85(12), 1995, pp. 3746-3753
HUMAN UMBILICAL-CORD BLOOD CD34+ 38(LO) CELLS ARE FUNCTIONALLY DISTINCT FROM ADULT BONE-MARROW CD34+/38(LO)/
Authors: REEMS JA TOROKSTORB B DONEY K
Citation: Ja. Reems et al., HUMAN UMBILICAL-CORD BLOOD CD34+ 38(LO) CELLS ARE FUNCTIONALLY DISTINCT FROM ADULT BONE-MARROW CD34+/38(LO)/, Experimental hematology, 22(8), 1994, pp. 753-753
APLASTIC-ANEMIA - ANALYSIS OF CYTOKINE PRODUCTION IN LONG-TERM MARROWCULTURES
Authors: HOLMBERG L SEIDEL K LEISENRING W TOROKSTORB B DONEY K
Citation: L. Holmberg et al., APLASTIC-ANEMIA - ANALYSIS OF CYTOKINE PRODUCTION IN LONG-TERM MARROWCULTURES, Experimental hematology, 22(8), 1994, pp. 769-769
EFFECT OF GRAFT-VERSUS-HOST DISEASE PROPHYLAXIS ON RELAPSE IN PATIENTS TRANSPLANTED FOR ACUTE MYELOID-LEUKEMIA
Authors: WEAVER CH CLIFT RA DEEG HJ STORB R APPELBAUM FR BENSINGER W DONEY K HANSEN JA MARTIN PO SANDERS J SULLIVAN KM THOMAS ED SINGER J WITHERSPOON R BUCKNER CD
Citation: Ch. Weaver et al., EFFECT OF GRAFT-VERSUS-HOST DISEASE PROPHYLAXIS ON RELAPSE IN PATIENTS TRANSPLANTED FOR ACUTE MYELOID-LEUKEMIA, Bone marrow transplantation, 14(6), 1994, pp. 885-893
MARROW TRANSPLANT EXPERIENCE FOR CHILDREN WITH SEVERE APLASTIC-ANEMIA
Authors: SANDERS JE STORB R ANASETTI C DEEG HJ DONEY K SULLIVAN KM WITHERSPOON RP HANSEN J
Citation: Je. Sanders et al., MARROW TRANSPLANT EXPERIENCE FOR CHILDREN WITH SEVERE APLASTIC-ANEMIA, The American journal of pediatric hematology/oncology, 16(1), 1994, pp. 43-49
TREATMENT OF ACUTE GRAFT-VERSUS-HOST DISEASE WITH HUMANIZED ANTI-TAC - AN ANTIBODY THAT BINDS TO THE INTERLEUKIN-2 RECEPTOR
Authors: ANASETTI C HANSEN JA WALDMANN TA APPELBAUM FR DAVIS J DEEG HJ DONEY K MARTIN PJ NASH R STORB R SULLIVAN KM WITHERSPOON RP BINGER MH CHIZZONITE R HAKIMI J MOULD D SATOH H LIGHT SE
Citation: C. Anasetti et al., TREATMENT OF ACUTE GRAFT-VERSUS-HOST DISEASE WITH HUMANIZED ANTI-TAC - AN ANTIBODY THAT BINDS TO THE INTERLEUKIN-2 RECEPTOR, Blood, 84(4), 1994, pp. 1320-1327
CYCLOPHOSPHAMIDE COMBINED WITH ANTITHYMOCYTE GLOBULIN IN PREPARATION FOR ALLOGENEIC MARROW TRANSPLANTS IN PATIENTS WITH APLASTIC-ANEMIA
Authors: STORB R ETZIONI R ANASETTI C APPELBAUM FR BUCKNER CD BENSINGER W BRYANT E CLIFT R DEEG HJ DONEY K FLOWERS M HANSEN J MARTIN P PEPE M SALE G SANDERS J SINGER J SULLIVAN KM THOMAS ED WITHERSPOON RP
Citation: R. Storb et al., CYCLOPHOSPHAMIDE COMBINED WITH ANTITHYMOCYTE GLOBULIN IN PREPARATION FOR ALLOGENEIC MARROW TRANSPLANTS IN PATIENTS WITH APLASTIC-ANEMIA, Blood, 84(3), 1994, pp. 941-949
FK506 IN COMBINATION WITH METHOTREXATE (MTX) FOR THE PREVENTION OF GRAFT-VERSUS-HOST DISEASE (GVHD) AFTER MARROW TRANSPLANTATION FROM PHENOTYPICALLY HLA-IDENTICAL UNRELATED DONORS
Authors: NASH RA MCSWEENEY PA STORB R GOOLEY T FURLONG T APPELBAUM F DEEG HJ DONEY K MARTIN P SULLIVAN K WITHERSPOON R ZAGER RA HANSEN JA ANASETTI C
Citation: Ra. Nash et al., FK506 IN COMBINATION WITH METHOTREXATE (MTX) FOR THE PREVENTION OF GRAFT-VERSUS-HOST DISEASE (GVHD) AFTER MARROW TRANSPLANTATION FROM PHENOTYPICALLY HLA-IDENTICAL UNRELATED DONORS, Blood, 84(10), 1994, pp. 10000394-10000394
LONG-TERM FOLLOW-UP OF A RANDOMIZED TRIAL OF GRAFT-VERSUS-HOST DISEASE PREVENTION BY METHOTREXATE CYCLOSPORINE VERSUS METHOTREXATE ALONE INPATIENTS GIVEN MARROW GRAFTS FOR SEVERE APLASTIC-ANEMIA/
Authors: STORB R LEISENRING W DEEG HJ ANASETTI C APPELBAUM F BENSINGER W BUCKNER CD CLIFT R DONEY K HANSEN J MARTIN P SANDERS J STEWART P SULLIVAN K THOMAS ED WITHERSPOON R
Citation: R. Storb et al., LONG-TERM FOLLOW-UP OF A RANDOMIZED TRIAL OF GRAFT-VERSUS-HOST DISEASE PREVENTION BY METHOTREXATE CYCLOSPORINE VERSUS METHOTREXATE ALONE INPATIENTS GIVEN MARROW GRAFTS FOR SEVERE APLASTIC-ANEMIA/, Blood, 83(9), 1994, pp. 2749-2750
CYCLOPHOSPHAMIDE PLUS ATG CONDITIONING IS INSUFFICIENT FOR SUSTAINED HEMATOPOIETIC RECONSTITUTION IN PATIENTS WITH SEVERE APLASTIC-ANEMIA TRANSPLANTED WITH MARROW FROM HLA-A, HLA-B, DRB MATCHED UNRELATED DONORS
Authors: DEEG HJ ANASETTI C PETERSDORF E STORB R DONEY K HANSEN JA SANDERS J SULLIVAN KM APPELBAUM FR
Citation: Hj. Deeg et al., CYCLOPHOSPHAMIDE PLUS ATG CONDITIONING IS INSUFFICIENT FOR SUSTAINED HEMATOPOIETIC RECONSTITUTION IN PATIENTS WITH SEVERE APLASTIC-ANEMIA TRANSPLANTED WITH MARROW FROM HLA-A, HLA-B, DRB MATCHED UNRELATED DONORS, Blood, 83(11), 1994, pp. 3417-3418
Risultati: 1-25 | 26-32